What is the mechanism of action of sodium-glucose cotransporter 2 inhibitors (SGLT-2 inhibitors)?
Blocks glucose reabsorption by the kidneys and increases glucose excretion to lower blood sugar
Interacts with the transcription factor that improves insulin sensitivity in the liver, skeletal muscle, and fat
Inhibits hepatic glucose production and increases insulin sensitivity in peripheral tissues
Blocks ATP-sensitive K+ channels on membrane of beta cells to promote insulin secretion
The Correct Answer is A
Choice A reason: SGLT-2 inhibitors, like empagliflozin, block sodium-glucose cotransporter 2 in the proximal tubule, preventing glucose reabsorption. This increases urinary glucose excretion, lowering blood sugar in type 2 diabetes. The mechanism is insulin-independent, reducing hyperglycemia and promoting weight loss, making this statement accurate for their primary action.
Choice B reason: SGLT-2 inhibitors do not interact with transcription factors to improve insulin sensitivity. This describes metformin’s action via AMPK activation in liver and muscle. SGLT-2 inhibitors act renally, not on transcription factors, making this statement inaccurate as it misattributes their mechanism to a different drug class.
Choice C reason: Inhibiting hepatic glucose production and increasing insulin sensitivity is metformin’s mechanism, not SGLT-2 inhibitors. SGLT-2 inhibitors work renally to excrete glucose, not by altering hepatic gluconeogenesis or peripheral insulin sensitivity. This statement is inaccurate, as it describes a different antidiabetic drug’s action.
Choice D reason: Blocking ATP-sensitive K+ channels is the mechanism of sulfonylureas, like glipizide, which stimulate insulin secretion from beta cells. SGLT-2 inhibitors act on renal glucose reabsorption, not beta cell channels. This statement is inaccurate, as it incorrectly assigns a sulfonylurea mechanism to SGLT-2 inhibitors.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Insulin lispro, a rapid-acting insulin, peaks 1-2 hours after administration (around 8:30-9:30 am for a 7:30 am dose). This peak coincides with maximum glucose-lowering effect, increasing hypoglycemia risk, especially if breakfast is inadequate or delayed. This time is the most likely for low blood sugar due to insulin’s pharmacodynamics.
Choice B reason: At 7:45 am, insulin lispro is just beginning to act (onset 15-30 minutes), and breakfast is likely being consumed, providing glucose to counter insulin’s effect. Hypoglycemia risk is lower than at peak action (1-2 hours), making this time less critical for hypoglycemia monitoring.
Choice C reason: By 12:30 pm, insulin lispro’s effect (duration 3-5 hours) is waning, and glucose from breakfast is metabolized. Hypoglycemia risk is lower unless additional insulin or activity occurs. This time is less likely for hypoglycemia compared to the peak action period around 8:30 am.
Choice D reason: Tomorrow at 6:30 am is beyond insulin lispro’s duration of action (3-5 hours). Hypoglycemia risk from the 7:30 am dose is negligible 23 hours later, as insulin is cleared. This time is irrelevant to the dose’s effect, making it the least likely for hypoglycemia.
Correct Answer is B
Explanation
Choice A reason: Melena, dark tarry stools from digested blood, indicates upper gastrointestinal bleeding, not typically GERD. GERD involves acid reflux causing esophageal irritation, not bleeding severe enough for melena. This statement is inaccurate, as melena is more associated with ulcers or varices, not reflux disease.
Choice B reason: Heartburn, a burning sensation in the chest, is a hallmark of GERD, caused by stomach acid refluxing into the esophagus, irritating the mucosa. It results from lower esophageal sphincter dysfunction, allowing acid backflow. This statement is accurate, as heartburn is a primary diagnostic symptom of GERD.
Choice C reason: Hematemesis, vomiting blood, is not a common GERD symptom but indicates severe conditions like esophageal varices or ulcers. While chronic GERD may lead to esophagitis, bleeding is rare. This statement is inaccurate, as hematemesis is not a characteristic feature of typical GERD presentations.
Choice D reason: Dysphagia, difficulty swallowing, can occur in severe GERD due to esophageal strictures or motility issues but is not a primary characteristic. Heartburn is more common and diagnostic. This statement is less accurate, as dysphagia is a complication, not a defining feature of GERD.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
